A phase III, randomized, double-blind placebo-controlled, multicenter study to evaluate the efficacy and safety of baloxavir marboxil in combination with standard-of-care neuraminidase inhibitor in hospitalized patients with severe influenza

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/46146/MonH-2018-152999(v1)
NMA SSA Reference Number: SSA/46146/MonH-2019-168845(v1)
Monash Health Ref: RES-18-0000-573A
Effective start/end date30/04/1929/04/24


  • Clinical trial
  • treatment efficacy
  • influenza